{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:09:57Z","timestamp":1789560597658,"version":"build-2803163510"},"reference-count":41,"publisher":"The Company of Biologists","issue":"10","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"crossref","award":["26-11"],"award-info":[{"award-number":["26-11"]}],"id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"crossref","award":["2-8"],"award-info":[{"award-number":["2-8"]}],"id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"crossref","award":["29-5"],"award-info":[{"award-number":["29-5"]}],"id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP16ak0101027"],"award-info":[{"award-number":["JP16ak0101027"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["26-005"],"award-info":[{"award-number":["26-005"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP23ek0109522"],"award-info":[{"award-number":["JP23ek0109522"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP19ek0109216"],"award-info":[{"award-number":["JP19ek0109216"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["26870884"],"award-info":[{"award-number":["26870884"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Neurodegenerative diseases, including polyglutamine diseases, remain a clinical challenge, partly because of limited animal models that recapitulate human disease. Here, we describe a second-generation transgenic marmoset model of spinocerebellar ataxia 3 (SCA3), a polyglutamine disease, which stably expresses expanded CAG repeats in ataxin 3 (ATXN3). All five offspring of the founder marmoset harbored the transgene with reduced transgene integration sites compared with the founder and without repeat instability or genetic mosaicism, offering improved construct validity. Three of the five marmosets developed progressive motor impairments that segregated into two distinct phenotypes \u2013 early onset with rapid progression and late onset with mild progression \u2013 accompanied by corresponding patterns in body weight gain and grip strength. Pathological analysis revealed cerebellar Purkinje cell loss, spinal cord neurodegeneration and widespread intranuclear inclusions. The severity of motor phenotypes correlated with transgene expression levels in disease-relevant brain regions, including the cerebellum and spinal cord. By overcoming the translational limitations of rodent systems, our second-generation model offers a powerful platform for investigating disease mechanisms and testing potential therapeutics, advancing the utility of transgenic marmosets as clinically relevant models of neurodegenerative diseases.<\/jats:p>","DOI":"10.1242\/dmm.052470","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:28:36Z","timestamp":1761906516000},"source":"Crossref","is-referenced-by-count":1,"title":["Establishment of a second-generation transgenic marmoset with germline transmission that models polyglutamine disease"],"prefix":"10.1242","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6204-9104","authenticated-orcid":false,"given":"Eiko N.","family":"Minakawa","sequence":"first","affiliation":[{"name":"National Institute of Neuroscience, National Center of Neurology and Psychiatry 1 Department of Neurophysiology , , Kodaira, Tokyo 187-8502 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Owari","sequence":"additional","affiliation":[{"name":"National Institute of Neuroscience, National Center of Neurology and Psychiatry 1 Department of Neurophysiology , , Kodaira, Tokyo 187-8502 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotake","family":"Nogami","sequence":"additional","affiliation":[{"name":"National Institute of Neuroscience, National Center of Neurology and Psychiatry 1 Department of Neurophysiology , , Kodaira, Tokyo 187-8502 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terumi","family":"Nakatani","sequence":"additional","affiliation":[{"name":"National Institute of Neuroscience, National Center of Neurology and Psychiatry 1 Department of Neurophysiology , , Kodaira, Tokyo 187-8502 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Koizumi","sequence":"additional","affiliation":[{"name":"National Institute of Neuroscience, National Center of Neurology and Psychiatry 1 Department of Neurophysiology , , Kodaira, Tokyo 187-8502 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyo","family":"Kawanobe","sequence":"additional","affiliation":[{"name":"National Institute of Neuroscience, National Center of Neurology and Psychiatry 1 Department of Neurophysiology , , Kodaira, Tokyo 187-8502 ,","place":["Japan"]},{"name":"The Corporation for Production and Research of Laboratory Primates 2 Department of Medical Science Project Planning and Support , , Tsukuba, Ibaragi 305-0003 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9186-524X","authenticated-orcid":false,"given":"Yosuke","family":"Saga","sequence":"additional","affiliation":[{"name":"National Institute of Neuroscience, National Center of Neurology and Psychiatry 1 Department of Neurophysiology , , Kodaira, Tokyo 187-8502 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moeko","family":"Kudo","sequence":"additional","affiliation":[{"name":"National Institute of Neuroscience, National Center of Neurology and Psychiatry 1 Department of Neurophysiology , , Kodaira, Tokyo 187-8502 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6165-3716","authenticated-orcid":false,"given":"Satoru","family":"Noguchi","sequence":"additional","affiliation":[{"name":"National Institute of Neuroscience, National Center of Neurology and Psychiatry 3 Department of Neuromuscular Research , , Kodaira, Tokyo 187-8502 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3267-8214","authenticated-orcid":false,"given":"Takashi","family":"Hanakawa","sequence":"additional","affiliation":[{"name":"Integrative Brain Imaging Center, National Center of Neurology and Psychiatry 4 , Kodaira, Tokyo 187-8551 ,","place":["Japan"]},{"name":"Kyoto University Graduate School of Medicine 5 Department of Integrated Neuroanatomy and Neuroimaging , , Sakyo, Kyoto 606-8501 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Hori","sequence":"additional","affiliation":[{"name":"Integrative Brain Imaging Center, National Center of Neurology and Psychiatry 4 , Kodaira, Tokyo 187-8551 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemi","family":"Numazawa","sequence":"additional","affiliation":[{"name":"Integrative Brain Imaging Center, National Center of Neurology and Psychiatry 4 , Kodaira, Tokyo 187-8551 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6236-8009","authenticated-orcid":false,"given":"Toshihide","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Life Science Research Institute, Kindai University 6 , Osaka-Sayama, Osaka 589-8511 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Katakai","sequence":"additional","affiliation":[{"name":"The Corporation for Production and Research of Laboratory Primates 2 Department of Medical Science Project Planning and Support , , Tsukuba, Ibaragi 305-0003 ,","place":["Japan"]},{"name":"National Institute of Neuroscience, National Center of Neurology and Psychiatry 7 Administrative Section of Primate Research Facility , , Kodaira, Tokyo 187-8502 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Saito","sequence":"additional","affiliation":[{"name":"National Institute of Neuroscience, National Center of Neurology and Psychiatry 7 Administrative Section of Primate Research Facility , , Kodaira, Tokyo 187-8502 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1037-3129","authenticated-orcid":false,"given":"Yoshitaka","family":"Nagai","sequence":"additional","affiliation":[{"name":"Life Science Research Institute, Kindai University 6 , Osaka-Sayama, Osaka 589-8511 ,","place":["Japan"]},{"name":"Kindai University Faculty of Medicine 8 Department of Neurology , , Osaka-Sayama, Osaka 589-8511 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9974-8638","authenticated-orcid":false,"given":"Yuko","family":"Saito","sequence":"additional","affiliation":[{"name":"National Center of Neurology and Psychiatry Hospital 9 Department of Pathology and Laboratory Medicine , , Kodaira, Tokyo 187-8551 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1471-6419","authenticated-orcid":false,"given":"Ikuo","family":"Tomioka","sequence":"additional","affiliation":[{"name":"Shinshu University 10 Laboratory of Applied Reproductive Science, Faculty of Agriculture , , Kami-Ina, Nagano 399-4598 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4262-9590","authenticated-orcid":false,"given":"Kazuhiko","family":"Seki","sequence":"additional","affiliation":[{"name":"National Institute of Neuroscience, National Center of Neurology and Psychiatry 1 Department of Neurophysiology , , Kodaira, Tokyo 187-8502 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"237","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"2025103106283239600_DMM052470C1","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S1474-4422(23)00274-0","article-title":"Preparing for disease-modifying therapies in Alzheimer's disease","volume":"22","author":"Belder","year":"2023","journal-title":"Lancet Neurol."},{"key":"2025103106283239600_DMM052470C2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.neuron.2015.03.021","article-title":"Brains, genes, and primates","volume":"86","author":"Belmonte","year":"2015","journal-title":"Neuron"},{"key":"2025103106283239600_DMM052470C3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/ilar\/ilt035","article-title":"Progress and prospects for genetic modification of nonhuman primate models in biomedical research","volume":"54","author":"Chan","year":"2013","journal-title":"ILAR J."},{"key":"2025103106283239600_DMM052470C4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3233\/JHD-190359","article-title":"Progressive polyglutamine repeat expansion in peripheral blood cells and sperm of transgenic Huntington's disease monkeys","volume":"8","author":"Clever","year":"2019","journal-title":"J. Huntington's Dis."},{"key":"2025103106283239600_DMM052470C5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.410390411","article-title":"Spinocerebellar ataxia 3 and Machado-Joseph disease: Clinical, molecular, and neuropathological features","volume":"39","author":"Durr","year":"1996","journal-title":"Ann. Neurol."},{"key":"2025103106283239600_DMM052470C6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12035-012-8315-4","article-title":"Mouse models of polyglutamine diseases: review and data table. Part I","volume":"46","author":"Figiel","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"2025103106283239600_DMM052470C7","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/mus.21396","article-title":"Prospective study of peripheral neuropathy in Machado\u2013Joseph disease","volume":"40","author":"Fran\u00e7a","year":"2009","journal-title":"Muscle Nerve"},{"key":"2025103106283239600_DMM052470C8","doi-asserted-by":"publisher","first-page":"735387","DOI":"10.3389\/fnbeh.2021.735387","article-title":"Measuring behavior in the home cage: study design, applications, challenges, and perspectives","volume":"15","author":"Grieco","year":"2021","journal-title":"Front. Behav. Neurosci."},{"key":"2025103106283239600_DMM052470C9","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","article-title":"Biomarkers for neurodegenerative diseases","volume":"27","author":"Hansson","year":"2021","journal-title":"Nat. Med."},{"key":"2025103106283239600_DMM052470C10","doi-asserted-by":"publisher","first-page":"102952","DOI":"10.1016\/j.eclinm.2024.102952","article-title":"L-arginine in patients with spinocerebellar ataxia type 6: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"78","author":"Ishihara","year":"2024","journal-title":"eClinicalMedicine"},{"key":"2025103106283239600_DMM052470C11","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41582-024-01023-0","article-title":"Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis","volume":"20","author":"Kalia","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"2025103106283239600_DMM052470C12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41582-020-00434-z","article-title":"Improving clinical trial outcomes in amyotrophic lateral sclerosis","volume":"17","author":"Kiernan","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"2025103106283239600_DMM052470C13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fnsys.2021.645308","article-title":"Motility profile of captive-bred marmosets revealed by a long-term in-cage monitoring system","volume":"15","author":"Koizumi","year":"2021","journal-title":"Front. Syst. Neurosci."},{"key":"2025103106283239600_DMM052470C14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000072836","article-title":"Trinucleotide repeat instability: a hairpin curve at the crossroads of replication, recombination, and repair","volume":"100","author":"Lenzmeier","year":"2003","journal-title":"Cytogenet Genome Res."},{"key":"2025103106283239600_DMM052470C15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-pathmechdis-012418-012857","article-title":"Polyglutamine repeats in neurodegenerative diseases","volume":"14","author":"Lieberman","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"2025103106283239600_DMM052470C16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nature16533","article-title":"Autism-like behaviours and germline transmission in transgenic monkeys overexpressing MeCP2","volume":"530","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"2025103106283239600_DMM052470C17","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41580-021-00382-6","article-title":"Molecular mechanisms underlying nucleotide repeat expansion disorders","volume":"22","author":"Malik","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2025103106283239600_DMM052470C18","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bcp.2013.08.006","article-title":"Animal models of human disease: challenges in enabling translation","volume":"87","author":"McGonigle","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"2025103106283239600_DMM052470C19","doi-asserted-by":"publisher","first-page":"104635","DOI":"10.1016\/j.nbd.2019.104635","article-title":"Pathogenesis of SCA3 and implications for other polyglutamine diseases","volume":"134","author":"McLoughlin","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"2025103106283239600_DMM052470C20","doi-asserted-by":"publisher","first-page":"621996","DOI":"10.3389\/fnins.2021.621996","article-title":"Protein aggregation inhibitors as disease-modifying therapies for polyglutamine diseases","volume":"15","author":"Minakawa","year":"2021","journal-title":"Front. Neurosci."},{"key":"2025103106283239600_DMM052470C21","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/brain\/awaa115","article-title":"Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation","volume":"143","author":"Minakawa","year":"2020","journal-title":"Brain"},{"key":"2025103106283239600_DMM052470C22","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.omtn.2017.04.005","article-title":"Evaluation of antisense oligonucleotides targeting ATXN3 in SCA3 mouse models","volume":"7","author":"Moore","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"2025103106283239600_DMM052470C23","doi-asserted-by":"publisher","first-page":"101504","DOI":"10.1016\/j.scr.2019.101504","article-title":"Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line","volume":"39","author":"Moore","year":"2019","journal-title":"Stem Cell Res."},{"key":"2025103106283239600_DMM052470C24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.theriogenology.2015.03.016","article-title":"Germline transmission in transgenic Huntington's disease monkeys","volume":"84","author":"Moran","year":"2015","journal-title":"Theriogenology"},{"key":"2025103106283239600_DMM052470C25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-4-431-54541-5_9","article-title":"Drug development for neurodegenerative diseases","volume-title":"Neurodegenerative Disorders as Systemic Diseases","author":"Nagai","year":"2015"},{"key":"2025103106283239600_DMM052470C26","volume-title":"Animal Environment, Housing, and Management, Guide for the Care and Use of Laboratory Animals","author":"National Research Council (US) Institute for Laboratory Animal Research","year":"1996"},{"key":"2025103106283239600_DMM052470C27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.pneurobio.2013.01.001","article-title":"Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7","volume":"104","author":"R\u00fcb","year":"2013","journal-title":"Prog. Neurobiol."},{"key":"2025103106283239600_DMM052470C28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature08090","article-title":"Generation of transgenic non-human primates with germline transmission","volume":"459","author":"Sasaki","year":"2009","journal-title":"Nature"},{"key":"2025103106283239600_DMM052470C29","doi-asserted-by":"publisher","first-page":"eabf4879","DOI":"10.1126\/scitranslmed.abf4879","article-title":"Modeling genetic diseases in nonhuman primates through embryonic and germline modification: considerations and challenges","volume":"14","author":"Schmidt","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"2025103106283239600_DMM052470C30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2169\/internalmedicine.1382-18","article-title":"Diagnostic challenges posed by preceding peripheral neuropathy in very late-onset spinocerebellar ataxia type 3","volume":"58","author":"Sugiyama","year":"2019","journal-title":"Intern. Med."},{"key":"2025103106283239600_DMM052470C31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00335-019-09798-0","article-title":"Model validity for preclinical studies in precision medicine: precisely how precise do we need to be?","volume":"30","author":"Tadenev","year":"2019","journal-title":"Mamm. Genome"},{"key":"2025103106283239600_DMM052470C32","doi-asserted-by":"publisher","first-page":"ENEURO.0250-16.2017","DOI":"10.1523\/ENEURO.0250-16.2017","article-title":"Transgenic monkey model of the polyglutamine diseases recapitulating progressive neurological symptoms","volume":"4","author":"Tomioka","year":"2017","journal-title":"eNeuro"},{"key":"2025103106283239600_DMM052470C33","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.4103\/1673-5374.235028","article-title":"Developing biomarkers for neurodegenerative diseases using genetically-modified common marmoset models","volume":"13","author":"Tomioka","year":"2018","journal-title":"Neural Regener. Res."},{"key":"2025103106283239600_DMM052470C34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/ilar\/ilt044","article-title":"Nonhuman primate models in the genomic era: a paradigm shift","volume":"54","author":"Vallender","year":"2013","journal-title":"ILAR J."},{"key":"2025103106283239600_DMM052470C35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1744-9081-5-11","article-title":"Evaluation of animal models of neurobehavioral disorders","volume":"5","author":"van der Staay","year":"2009","journal-title":"Behav. Brain Funct."},{"key":"2025103106283239600_DMM052470C36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bbr.2009.01.022","article-title":"Two new test methods to quantify motor deficits in a marmoset model for Parkinson's disease","volume":"200","author":"Verhave","year":"2009","journal-title":"Behav. Brain Res."},{"key":"2025103106283239600_DMM052470C37","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1007\/s00109-008-0381-8","article-title":"Targeted gene insertion for molecular medicine","volume":"86","author":"Voigt","year":"2008","journal-title":"J. Mol. Med."},{"key":"2025103106283239600_DMM052470C38","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1136\/jmg.2007.050930","article-title":"Factors associated with HD CAG repeat instability in Huntington disease","volume":"44","author":"Wheeler","year":"2007","journal-title":"J. Med. Genet."},{"key":"2025103106283239600_DMM052470C39","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"2025103106283239600_DMM052470C40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s004010000277","article-title":"Involvement of the cerebral cortex and autonomic ganglia in Machado-Joseph disease","volume":"101","author":"Yamada","year":"2001","journal-title":"Acta Neuropathol."},{"key":"2025103106283239600_DMM052470C41","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nature06975","article-title":"Towards a transgenic model of Huntington's disease in a non-human primate","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"}],"container-title":["Disease Models &amp; Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.052470\/3671435\/dmm052470.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.biologists.com\/dmm\/article-pdf\/doi\/10.1242\/dmm.052470\/3671435\/dmm052470.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T10:28:39Z","timestamp":1761906519000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.biologists.com\/dmm\/article\/18\/10\/dmm052470\/369685\/Establishment-of-a-second-generation-transgenic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1242\/dmm.052470","relation":{},"ISSN":["1754-8403","1754-8411"],"issn-type":[{"value":"1754-8403","type":"print"},{"value":"1754-8411","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"dmm052470"}}